biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Baggers: 10, 20, 50, 162

<< Previous

Bullboard Posts

Next >>

Comment by JDavenporton Nov 03, 2022 1:46pm

134 Views

Post# 35070344

RE:RE:Baggers: 10, 20, 50, 162

Tell us how it works, big boy. All of us the right to express our opinions.

Tell us why you think Bioasis cannot be compared to Denali.

Tell us how you think that Bioasis will get itself on NASDAQ.

I won't bite you. I'd rather debate you.

Or are just a bigoted creep?

About education, I try not to humiliate others about theirs, although I will take off the gloves when I encounter hate and bigotry.

jd

<< Previous

Bullboard Posts

Next >>

Shopify stock hits year-high on Q3 results